WeVote

Bill

Bill

H 528

DIRECTED BLOOD PRODUCT TRANSFUSION – Adds to existing law to establish provisions regarding directed blood product transfusion.

68th Legislature, 2nd Regular Session (2026)

Idaho law now permits patients to request specific blood donors for transfusions, effective July 2026, establishing procedures and liability frameworks for directed blood product donations.

Reported Signed by Governor on March 16, 2026 Session Law Chapter 26 Effective: 07/01/2026
0
WeVote Research Nonpartisan
Bill Summary · H 528

Legislative bill overview

H 528 establishes legal provisions governing directed blood product transfusions in Idaho, allowing patients to designate specific blood donors for their transfusions. The bill became effective on July 1, 2026, following gubernatorial signature in March 2026.

Why is this important

Directed transfusions can address patient preferences, religious beliefs, or concerns about blood safety, but they also create logistical and medical complications for healthcare providers. The law clarifies liability, procedural requirements, and circumstances under which directed donations are permitted or denied within Idaho's healthcare system.

Potential points of contention

  • Medical efficacy vs. patient autonomy: Directed donations may increase costs and administrative burden while providing unproven safety benefits over standard blood screening protocols
  • Discrimination concerns: Criteria for accepting or rejecting directed donors could raise questions about equal treatment and potential exclusionary practices
  • Healthcare provider liability: The law must clarify whether hospitals bear responsibility if directed blood causes adverse outcomes or if patients assume greater liability

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.